IRONWOOD PHARMACEUTICALS INC Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Ironwood Pharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $773K, a 2.11% increase year-over-year.
  • Ironwood Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $3.07M, a 1.57% decline from 2022.
  • Ironwood Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $3.11M, a 0.45% decline from 2021.
  • Ironwood Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $3.13M, a 173% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $773K +$16K +2.11% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $757K -$32K -4.06% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $789K +$16K +2.07% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $773K +$730K +1698% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $43K -$4.37M -99% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $4.41M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.